Stanozolol

CAS 10418-03-8

In Stock

Stanozolol

Cat. No. STUB-API-STANOZOLOLCAS 10418-03-8In Stock

Technical Data

Cat. No.STUB-API-STANOZOLOL

CAS10418-03-8

Mol. FormulaC₂₁H₃₂N₂O

Mol. Weight328.5 g/mol

IUPAC(1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol

SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC5=C(C4)NN=C5)C

InChIInChI=1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1

InChI KeyLKAJKIOFIWVMDJ-IYRCEVNGSA-N

Purity—

Description

Overview

Stanozolol can be administered orally or intramuscularly. Some of its therapeutic uses include the treatment of aplastic anemia and hereditary angioedema. It has also been indicated as an adjunct therapy for the treatment of various other medical conditions such as vascular disorders and growth failure

Anant Labs manufacture and furnish high quality Stanozolol impurities for global markets. Our Stanozolol EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.